Suppr超能文献

利用电子健康记录监测宫内阿片类药物暴露情况。

Surveillance of Intrauterine Opioid Exposures Using Electronic Health Records.

作者信息

Hall Eric S, Wexelblatt Scott L, Greenberg James M

机构信息

1 Perinatal Institute, Cincinnati Children's Hospital Medical Center , Cincinnati, Ohio.

2 Department of Pediatrics, University of Cincinnati College of Medicine , Cincinnati, Ohio.

出版信息

Popul Health Manag. 2018 Dec;21(6):486-492. doi: 10.1089/pop.2017.0184. Epub 2018 Feb 27.

Abstract

The objective was to use population-based electronic health records for surveillance of intrauterine exposures to substances of abuse, including opioids, and to monitor changes in exposure rates over time. This retrospective, descriptive analysis utilized geocoded neonatal physician billing records representing intrauterine exposures to substances of abuse detected through universal maternal drug testing. Census tract-level exposure rates were identified among the newborn population of Hamilton County, Ohio between 2014 and 2016. Among 27,896 newborns, the authors detected an intrauterine opioid exposure rate of 37.9 per 1000 infants, with 10.5 per 1000 experiencing severe opioid withdrawal (neonatal abstinence syndrome). Individual data were mapped to 222 US census tracts. Tract-level opioid exposure rates ranged from 0.0 to 607.1 (median: 32.9) per 1000 live births. Secondary use of electronic health record data has potential to aid in intrauterine opioid exposure and other public health surveillance efforts without disrupting clinical workflows or placing an additional burden on limited resources. Surveillance of intrauterine opioid exposures may inform stakeholders and enable targeting of interventions and prevention strategies toward the highest risk populations.

摘要

目的是利用基于人群的电子健康记录监测子宫内药物滥用暴露情况,包括阿片类药物,并监测暴露率随时间的变化。这项回顾性描述性分析利用了地理编码的新生儿医生计费记录,这些记录代表了通过普遍的孕产妇药物检测发现的子宫内药物滥用暴露情况。在2014年至2016年期间,确定了俄亥俄州汉密尔顿县新生儿人群中的普查区层面暴露率。在27896名新生儿中,作者检测到每1000名婴儿中有37.9例子宫内阿片类药物暴露,每1000名中有10.5例经历严重阿片类药物戒断(新生儿戒断综合征)。个体数据被映射到222个美国普查区。普查区层面的阿片类药物暴露率范围为每1000例活产0.0至607.1(中位数:32.9)。电子健康记录数据的二次使用有潜力帮助进行子宫内阿片类药物暴露及其他公共卫生监测工作,而不会扰乱临床工作流程或给有限资源带来额外负担。子宫内阿片类药物暴露监测可为利益相关者提供信息,并使干预措施和预防策略能够针对风险最高的人群。

相似文献

1
Surveillance of Intrauterine Opioid Exposures Using Electronic Health Records.
Popul Health Manag. 2018 Dec;21(6):486-492. doi: 10.1089/pop.2017.0184. Epub 2018 Feb 27.
2
Developmental Disorders and Medical Complications Among Infants with Subclinical Intrauterine Opioid Exposures.
Popul Health Manag. 2019 Feb;22(1):19-24. doi: 10.1089/pop.2018.0016. Epub 2018 Jun 12.
3
Neonatal Abstinence Syndrome in West Virginia Substate Regions, 2007-2013.
J Rural Health. 2017 Jan;33(1):92-101. doi: 10.1111/jrh.12174. Epub 2016 Feb 16.
4
Subclinical and Overt Newborn Opioid Exposure: Prevalence and First-Year Healthcare Utilization.
J Pediatr. 2020 Jul;222:52-58.e1. doi: 10.1016/j.jpeds.2020.03.052. Epub 2020 May 15.
6
Public Health Surveillance of Prenatal Opioid Exposure in Mothers and Infants.
Pediatrics. 2019 Mar;143(3). doi: 10.1542/peds.2018-3801. Epub 2019 Jan 17.
7
Trends of Neonatal Abstinence Syndrome Epidemic and Maternal Risk Factors in Florida.
Pharmacotherapy. 2017 Jul;37(7):806-813. doi: 10.1002/phar.1947. Epub 2017 Jun 21.
8
Universal maternal drug testing in a high-prevalence region of prescription opiate abuse.
J Pediatr. 2015 Mar;166(3):582-6. doi: 10.1016/j.jpeds.2014.10.004. Epub 2014 Nov 12.
9
Ohio Perinatal Quality Collaborative Improves Care of Neonatal Narcotic Abstinence Syndrome.
Pediatrics. 2018 Apr;141(4). doi: 10.1542/peds.2017-0900. Epub 2018 Mar 7.
10
Identification of Prenatal Opioid Exposure Within Health Administrative Databases.
Pediatrics. 2021 Jan;147(1). doi: 10.1542/peds.2020-018507. Epub 2020 Dec 29.

引用本文的文献

2
Rates of substance and polysubstance use through universal maternal testing at the time of delivery.
J Perinatol. 2022 Aug;42(8):1026-1031. doi: 10.1038/s41372-022-01335-3. Epub 2022 Feb 17.
3
Well-Child Care Adherence After Intrauterine Opioid Exposure.
Pediatrics. 2020 Feb;145(2). doi: 10.1542/peds.2019-1275. Epub 2020 Jan 2.
4
Developmental Disorders and Medical Complications Among Infants with Subclinical Intrauterine Opioid Exposures.
Popul Health Manag. 2019 Feb;22(1):19-24. doi: 10.1089/pop.2018.0016. Epub 2018 Jun 12.

本文引用的文献

1
Maternal Substance Use Disorders and Infant Outcomes in the First Year of Life among Massachusetts Singletons, 2003-2010.
J Pediatr. 2017 Dec;191:69-75. doi: 10.1016/j.jpeds.2017.08.045. Epub 2017 Oct 16.
2
Rural and Appalachian Disparities in Neonatal Abstinence Syndrome Incidence and Access to Opioid Abuse Treatment.
J Rural Health. 2018 Dec;34(1):6-13. doi: 10.1111/jrh.12251. Epub 2017 Jul 7.
3
Evaluation of identifier field agreement in linked neonatal records.
J Perinatol. 2017 Aug;37(8):969-974. doi: 10.1038/jp.2017.70. Epub 2017 May 11.
4
A Public Health Response to Opioid Use in Pregnancy.
Pediatrics. 2017 Mar;139(3). doi: 10.1542/peds.2016-4070. Epub 2017 Feb 20.
5
Neonatal Abstinence Syndrome.
N Engl J Med. 2016 Dec 22;375(25):2468-2479. doi: 10.1056/NEJMra1600879.
6
Rural and Urban Differences in Neonatal Abstinence Syndrome and Maternal Opioid Use, 2004 to 2013.
JAMA Pediatr. 2017 Feb 1;171(2):194-196. doi: 10.1001/jamapediatrics.2016.3750.
7
Rates of Neonatal Abstinence Syndrome Amid Efforts to Combat the Opioid Abuse Epidemic.
JAMA Pediatr. 2016 Nov 1;170(11):1110-1112. doi: 10.1001/jamapediatrics.2016.2150.
8
Incidence of Neonatal Abstinence Syndrome - 28 States, 1999-2013.
MMWR Morb Mortal Wkly Rep. 2016 Aug 12;65(31):799-802. doi: 10.15585/mmwr.mm6531a2.
9
Neonatal Abstinence Syndrome in West Virginia Substate Regions, 2007-2013.
J Rural Health. 2017 Jan;33(1):92-101. doi: 10.1111/jrh.12174. Epub 2016 Feb 16.
10
Cohort Analysis of a Pharmacokinetic-Modeled Methadone Weaning Optimization for Neonatal Abstinence Syndrome.
J Pediatr. 2015 Dec;167(6):1221-5.e1. doi: 10.1016/j.jpeds.2015.09.038. Epub 2015 Oct 21.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验